These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 34512166)
1. A combination therapy of Phages and Antibiotics: Two is better than one. Li X; He Y; Wang Z; Wei J; Hu T; Si J; Tao G; Zhang L; Xie L; Abdalla AE; Wang G; Li Y; Teng T Int J Biol Sci; 2021; 17(13):3573-3582. PubMed ID: 34512166 [TBL] [Abstract][Full Text] [Related]
2. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy. Tagliaferri TL; Jansen M; Horz HP Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237 [TBL] [Abstract][Full Text] [Related]
3. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations. Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889 [TBL] [Abstract][Full Text] [Related]
4. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW mBio; 2020 Aug; 11(4):. PubMed ID: 32753497 [TBL] [Abstract][Full Text] [Related]
6. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection. Shariati A; Noei M; Chegini Z J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167 [TBL] [Abstract][Full Text] [Related]
7. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli. Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884 [TBL] [Abstract][Full Text] [Related]
8. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going? Luong T; Salabarria AC; Roach DR Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528 [TBL] [Abstract][Full Text] [Related]
9. A simple solid media assay for detection of synergy between bacteriophages and antibiotics. Khong E; Oh JJ; Jimenez JM; Liu R; Dunham S; Monsibais A; Rhoads A; Ghatbale P; Garcia A; Cobián Güemes AG; Blanc AN; Chiu M; Kuo P; Proost M; Kline A; Aslam S; Schooley RT; Whiteson K; Fraley SI; Pride DT Microbiol Spectr; 2024 May; 12(5):e0322123. PubMed ID: 38526142 [TBL] [Abstract][Full Text] [Related]
10. Phage-antibiotic synergy: Cell filamentation is a key driver of successful phage predation. Bulssico J; PapukashvilI I; Espinosa L; Gandon S; Ansaldi M PLoS Pathog; 2023 Sep; 19(9):e1011602. PubMed ID: 37703280 [TBL] [Abstract][Full Text] [Related]
11. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far. Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477 [TBL] [Abstract][Full Text] [Related]
12. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope. Kulshrestha M; Tiwari M; Tiwari V Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110 [TBL] [Abstract][Full Text] [Related]
13. Phage-Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency. Liu C; Hong Q; Chang RYK; Kwok PCL; Chan HK Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625214 [TBL] [Abstract][Full Text] [Related]
14. Evolutionary Rationale for Phages as Complements of Antibiotics. Torres-Barceló C; Hochberg ME Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863 [TBL] [Abstract][Full Text] [Related]
15. Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028 [TBL] [Abstract][Full Text] [Related]
16. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics. Usman SS; Uba AI; Christina E Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288 [TBL] [Abstract][Full Text] [Related]
17. Phage-antibiotic combinations: a promising approach to constrain resistance evolution in bacteria. North OI; Brown ED Ann N Y Acad Sci; 2021 Jul; 1496(1):23-34. PubMed ID: 33175408 [TBL] [Abstract][Full Text] [Related]
18. Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity. Kamal F; Dennis JJ Appl Environ Microbiol; 2015 Feb; 81(3):1132-8. PubMed ID: 25452284 [TBL] [Abstract][Full Text] [Related]
19. Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogens. Ragupathi NKD; Muthuirulandi Sethuvel DP; Gopikrishnan M; Dwarakanathan HT; Murugan D; Biswas I; Bakthavachalam YD; Murugesan M; George Priya Doss C; Monk PN; Karunakaran E; Veeraraghavan B Microb Pathog; 2023 May; 178():106064. PubMed ID: 36898591 [TBL] [Abstract][Full Text] [Related]
20. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy. Segall AM; Roach DR; Strathdee SA Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]